Laporan Laba Rugi (TTM)
Laporan Laba Rugi Biodexa Pharmaceuticals Plc - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 33.97 | 25.35 | 0.17 | 0.17 | 5.80 | 5.48 | 4.19 | 4.02 | -12.16 | -13.84 | -13.99 | -16.26 | -39.11 | -64.22 | -50.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 6 | 3 | 2 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | -0 | -0 | 5 |
| Change (%) | -44.98 | -29.64 | 123.14 | -11.21 | 4.33 | 4.15 | 0.53 | 0.53 | -1.58 | -1.61 | -8.91 | -9.78 | -100.76 | 100.00 | -7,714.52 | |
| % of Revenue | 1,769.10 | 726.55 | 407.81 | 908.41 | 805.19 | 794.03 | 784.03 | 756.55 | 731.19 | 819.22 | 935.54 | 990.77 | 1,067.45 | -13.36 | -74.70 | 11,375.90 |
| Gross Operating Profit | -6 | -3 | -2 | -5 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | -4 | 0 | 0 | -5 |
| Change (%) | -49.71 | -38.42 | 163.09 | -12.62 | 4.12 | 3.96 | -0.00 | -0.00 | 0.09 | 0.09 | -8.30 | -9.06 | -107.14 | -44.87 | -3,327.24 | |
| % of Revenue | -1,669.10 | -626.55 | -307.81 | -808.41 | -705.19 | -694.03 | -684.03 | -656.55 | -631.19 | -719.22 | -835.54 | -890.77 | -967.45 | 113.36 | 174.70 | -11,275.90 |
| SG&A | 5 | 4 | 3 | 4 | 3 | 3 | 3 | 3 | 5 | 3 | 4 | 5 | 3 | 3 | 3 | 3 |
| Change (%) | -27.40 | -17.74 | 24.06 | -19.80 | 3.28 | 3.17 | 0.68 | 43.71 | -25.08 | 6.49 | 29.36 | -35.32 | -4.24 | -4.43 | 18.34 | |
| % of Revenue | 1,445.48 | 783.35 | 514.06 | 636.66 | 509.69 | 497.55 | 486.67 | 470.31 | 649.79 | 554.23 | 685.07 | 1,030.33 | 795.80 | 1,251.51 | 3,343.37 | 7,913.25 |
| R&D | 4 | 4 | ||||||||||||||
| Change (%) | 0.00 | |||||||||||||||
| % of Revenue | 1,709.91 | 4,779.52 | ||||||||||||||
| OpEx | 11 | 7 | 5 | 9 | 8 | 8 | 8 | 8 | 10 | 8 | 9 | 9 | 7 | 7 | 7 | 8 |
| Change (%) | -37.26 | -23.78 | 68.63 | -14.70 | 4.03 | 3.88 | 0.51 | 17.04 | -12.58 | 1.76 | 7.23 | -22.87 | -3.66 | -2.34 | 19.75 | |
| % of Revenue | 3,211.08 | 1,503.92 | 914.41 | 1,539.25 | 1,310.73 | 1,288.88 | 1,269.30 | 1,224.55 | 1,377.83 | 1,371.17 | 1,619.47 | 2,018.90 | 1,859.58 | 2,942.03 | 8,031.33 | 19,234.94 |
| Operating Income | -11 | -6 | -5 | -8 | -7 | -7 | -8 | -8 | -9 | -8 | -8 | -9 | -7 | -7 | -7 | -8 |
| Change (%) | -39.55 | -27.28 | 77.03 | -15.73 | 3.89 | 3.74 | 0.20 | 18.20 | -12.62 | 2.99 | 8.62 | -23.22 | -1.65 | -0.16 | 20.63 | |
| % of Revenue | -3,111.08 | -1,403.92 | -814.41 | -1,439.25 | -1,210.73 | -1,188.88 | -1,169.30 | -1,124.55 | -1,277.83 | -1,271.17 | -1,519.47 | -1,918.90 | -1,759.58 | -2,842.03 | -7,931.33 | -19,134.94 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -0.00 | -0.00 | 14.71 | 12.82 | 2.27 | 2.22 | 7.61 | 7.07 | -1.89 | -1.92 | -9.80 | -10.87 | 32.93 | 24.77 | 71.32 | |
| % of Revenue | -9.91 | -7.40 | -5.90 | -6.76 | -7.61 | -7.36 | -7.13 | -7.37 | -7.58 | -8.47 | -9.64 | -10.11 | -10.76 | -23.49 | -81.93 | -280.72 |
| Net Income | -22 | -15 | -8 | -7 | -5 | -5 | -5 | -7 | -8 | -8 | -8 | -8 | -7 | -7 | -7 | -6 |
| Change (%) | -32.15 | -47.38 | -15.54 | -18.40 | -0.85 | -0.86 | 21.32 | 17.58 | 3.31 | 3.21 | -6.64 | -7.11 | -1.84 | -1.87 | -7.99 | |
| % of Revenue | -6,469.10 | -3,276.61 | -1,375.52 | -1,159.71 | -944.64 | -885.28 | -832.09 | -968.97 | -1,095.28 | -1,288.19 | -1,543.10 | -1,674.95 | -1,858.01 | -2,995.26 | -8,215.66 | -15,118.07 |
Source: Capital IQ
